QUOTE AND NEWS
DailyFinance  Apr 10  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 04/10/14 -- Lorus Therapeutics Inc. (TSX:LOR) (Lorus") reported financial results for the three and nine months ended February 28, 2014 and provided an update on recent accomplishments. Unless specified...
DailyFinance  Apr 8  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 04/08/14 -- Lorus Therapeutics Inc. (TSX:LOR) today announced it intends to release financial results for the quarter ended February 28, 2014, on Thursday, April 10, 2014 after the close of the market. The...
DailyFinance  Apr 8  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 04/08/14 -- Lorus Therapeutics Inc. (TSX:LOR) today announced the presentation of preclinical data for LOR-253, the company's lead anti-cancer agent, at the American Association for Cancer Research (AACR)...
DailyFinance  Apr 4  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 04/04/14 -- Lorus Therapeutics Inc. (TSX: LOR) today announced it will present preclinical data for LOR-253 in acute myeloid leukemia (AML) and other hematologic cancers at the American Association for Cancer...
DailyFinance  Mar 19  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 03/19/14 -- Lorus Therapeutics Inc. (TSX:LOR) ("Lorus" or the "Company") announced that Dr. Aiping Young is leaving her position as President and Chief Operating Officer of Lorus, effective today. William G....
DailyFinance  Mar 5  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 03/05/14 -- Lorus Therapeutics Inc. (TSX: LOR) today announced that William G. Rice, Ph.D., Chairman and Chief Executive Officer, will present at the 26th Annual ROTH Conference at 3:00 p.m. PT on Tuesday,...
DailyFinance  Feb 24  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 02/24/14 -- Lorus Therapeutics Inc. (TSX: LOR) today announced that William G. Rice, Ph.D., Chairman and Chief Executive Officer, will present at the RBC Capital Markets 2014 Global Healthcare Conference on...
DailyFinance  Jan 13  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 01/13/14 -- Lorus Therapeutics Inc. (TSX: LOR) today announced that William G. Rice, Ph.D., Chairman and Chief Executive Officer, will be presenting at Biotech Showcase 2014 on Wednesday, January 15, 2014,...
DailyFinance  Jan 8  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 01/08/14 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Company") announces that the underwriters have exercised in full their over-allotment option to purchase an additional 1,909,500 common shares...
DailyFinance  Jan 8  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 01/07/14 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Company") reported financial results for the three and six months ended November 30, 2013 and provided an update on recent accomplishments....





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki